ZyVersa Therapeutics (ZVSA) Institutional Ownership → The #1 Crypto That You Don’t Own… Yet (From Crypto 101 Media) (Ad) Free ZVSA Stock Alerts $4.94 +0.86 (+21.08%) (As of 05/31/2024 ET) Add Compare Share Share OwnershipStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for ZyVersa Therapeutics (NASDAQ:ZVSA)CurrentInstitutional OwnershipPercentage3.91%Number ofInstitutional Buyers(last 12 months)1TotalInstitutional Inflows(last 12 months)$10.34MNumber ofInstitutional Sellers(last 12 months)0 Get ZVSA Insider Trade Alerts Want to know when executives and insiders are buying or selling ZyVersa Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Ad Crypto 101 MediaShocking $16T Elon Musk Crypto LeakReports of a leaked meeting between Elon Musk and staff at X.com could send shockwaves through the crypto market. Musk revealed a "mind-blowing" plan to take over the global payment system. In his own words, the world's richest man said "you won't need a bank account." Prominent voices in crypto believe what comes next will mirror a crypto mass adoption similar to the one that triggered bitcoin's last bull run.Click here now to get your copy. ZyVersa Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails7/27/2023 Virtu Financial LLC120,377$30K0.0%N/A0.595% 4/17/2023 Winthrop Advisory Group LLC13,361$26K0.0%N/A0.145% (Data available from 1/1/2016 forward) ZVSA Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of ZVSA shares? During the previous two years, the following institutional investors and hedge funds held shares of ZyVersa Therapeutics shares: Virtu Financial LLC ($30K), Winthrop Advisory Group LLC ($26K).Learn more on ZVSA's institutional investors. What percentage of ZyVersa Therapeutics stock is owned by institutional investors? 3.91% of ZyVersa Therapeutics stock is owned by institutional investors. Learn more on ZVSA's institutional investor holdings. Which institutional investors have been buying ZyVersa Therapeutics stock? The following institutional investors have purchased ZyVersa Therapeutics stock in the last 24 months: Virtu Financial LLC ($120.38K), and Winthrop Advisory Group LLC ($13.36K). How much institutional buying is happening at ZyVersa Therapeutics? Institutional investors have bought a total of 133,738 shares in the last 24 months. This purchase volume represents approximately $19.37M in transactions. Related Companies: KPRX Major Shareholders EDSA Major Shareholders HUGE Major Shareholders RDHL Major Shareholders PIRS Major Shareholders RNAZ Major Shareholders MIRA Major Shareholders ELAB Major Shareholders AVTX Major Shareholders VAXX Major Shareholders This page (NASDAQ:ZVSA) was last updated on 6/1/2024 by MarketBeat.com Staff From Our PartnersThe #1 Crypto That You Don’t Own… YetCrypto 101 MediaBiden Nomination CANCELED?The Freeport SocietyOn June 10, Nvidia makes its next big moveWeiss RatingsMAJOR BUY SIGNAL: Move Fast, Washington/Pelosi/Mill…AltimetryUnlock Explosive Gains with This Defense StockBehind the MarketsMust-See: Elon’s New Invention is Absolutely InsaneInvestorPlaceClaim Your Complimentary Bitcoin RewardCrypto Swap ProfitsTrump’s Gift Could Unleash $51 Billion in New WealthWealthpin Pro Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ZyVersa Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.